portal hypertension
TRANSCRIPT
PORTAL HYPERTENSION
-Dr Sunil Kumar .K.P
DEFINITION
o Normal portal pressure is 5-7 mm Hg Pressure more than 10 mmHg is considered as portal hypertension
ANATOMY
o PV is formed by SV and SMV Left gastric vein ,superior pancreatico duodenal vein and pyloric vein
Normal portal blood flow is 1000-1200 ml/min
Normal hepatic arterial blood flow is 400 ml/min
CLASSIFICATION 1.Prehepatic
a) Presinusoidal-- EHPVO 2.Intrahepatic a) Presinusoidal--NCPF,Schistosomiasis b) Sinusoidal--Cirrhosis 3.Post hepatic a)Post sinusoidal-- Hepatic vein obstruction, Constrictive pericarditis
ETIOLOGY
• CIRRHOSIS <50% ETIOLOGY INDIA WEST
Cirrhosis <50% >80%
NCPF 10 – 20% 3 – 5%
EHPVO 30 – 40 % 5 %
ETIOLOGY INDIA WEST
Cirrhosis < 50 % >80%
NCPF 10 – 20 % 3 – 5 %
EHPVO 30 – 40 % 5 %
Budd Chiari syndrome
8 - 26% Rare
NON CIRRHOTIC PORTAL FIBROSIS• Perisinusoidal fibrosis 30 –
40 yr age group Neonatal umbilical sepsis Neonatal peritonitis Umbilical card catheterisation Congenital abnormalities ---- atresia,stenosis of PV Hypercoagulable states -polycythemia rubra vera -myelofibrisis -protein C deficiency - protein S deficiency -antithrombin III -chronic pancreatitis -pancreatic malignancy
LEFT SIDED PORTAL HYPERTENSION
• Seen in isolated splenic vein thrombosis• Causes development of isolated fundic varices
Causes – chronic pancreatitis
pancreatic malignacy hyper coagulable state idiopathic
BUDD CHIARI SYNDROME
• In India incidence is 8 – 26% of all cases of PHT• Type I – Major hepatic vein obstruction• Type II – IVC obstruction above the level of HV• Type III – IVC + HV obstruction Causes – pregnancy related hypercoagulability infection IVC web or web hypercoagulable states
NATURAL HISTIRY OF PHT
EHPVO
CLINICAL FEATURES
1) Gastrointestinal bleeding- 30% of cirrhotics bleed 90% of EHPVO and NCPF bleed stops spontaneously in 50% of cirrhotics
& 90% of EHPVO Rebleeding is more common in first 6
weeks,highest during first 24-48 hrs Mortality is related to Child’s criteria
2) SPLEENOMEGALY
present in all cases of PHT usually mild in cirrhotics moderate in NCPF & EHPVO can present as left hypochondriac pain or
abdominal lump
3) HYPERSPLENISM Leucopenia( WBC <4000/ml) and
thrombocytopenia ( platelets < 1 lakh /ml) Hypersplenism per se doesn’t need any
treatmentSymptomatic hypersplenism –recurrent
sepsis,petechiae,low hb,platelet <50000/ml and WBC < 2000/ml needs surgical intervention
• 3) ASCITIS
Sign of hepatic decompensation
In NCPH transient after bleeding
Clinical examination
- Puddle sign
- Shifting dullness
- Horse shoe dullness
- Fluid thrill
4) HEPATIC ENCEPHALOPATHYSign of hepatic decompensationEarly C/F are alterred sleep pattern & change in
hand writingGrading of encephalopathy Grade I :euphoria,slurred speech, , slurredspeech,depression,change in
sleep pattern Grade II :Drowsy ,inappropriate behaviour Grade III : Excessive sleepines,
arousable,confusion Grade IV :Hepatic coma
4) OBSTRUCTIVE JAUNDICE It is due to extrinisc compression by the
periportal & pericholedochal varices.
INVESTIGATION 1) Hematological- Complete haemogram to look for anemia & to rule out hyeprsplenism 2) BIOCHEMICAL- a) LFT- -To differentiate cirrhosis from NCPF -detect active disease which is a contraindication for surgery -Child classification
b) RFT- done in all patients 3)Coagulation profile- -PT, aPTT, BT, CT - Hypercoagulable work up done in
Buddchiari syndrome, PV thrombosis, left sided PHT
4) Viral markers- -HBsAg, anti HCV in all suspected cases of
cirrhosis - also done in patients with h/o transfusion
• 5) Liver scan – -to differentiate b/w cirrhosis & NC PHT
-degree of liver damage - decreased uptake s/o cirrhosis 6) Liver biopsy- Indications– etiology,to r/o secondary
cirrhosis Contraindication- ascites , coagulopathy Methods- percutaneous, transjugular
6) Upper gastrointestinal endoscopy all suspected or diagnosed cases to document to grade to R/O other causes
STIGMATA OF VARICEAL BLEED ON UGI SCOPY spurt or ooze adherent clot white platelet nipple on varix no other causes
Indicators of bleeding -varices upon varices -cherry red spots - grade IV varices
Endoscopic grading of varices• Grade I –visible on valsalva manoure• Grade II –occupy < 25% of lumen• Grade III -25- 50 % • Grade IV - > 50%( obliterating lumen)
Gastric varices classification
1) Primary- present before est
2) Secondary- develop during or after E S T
Hosking”s classification
Type I OV extending across GE junction
Type II fundic varices which converge to cardia
Type III fundic varices or absence of OV
SARIN”S CLASSIFICATION
a) Gastro esophageal varices( GOV) Type I – most common type,continuation of
esophageal varices Type II – extend upto fundus b) Isolated gastric varices Type I – fundic Type II – isolated ectopic varices
Mathur’s Classification- Type I – lesser curve gastric varices Type II – FGV+EV a) subcardiac – respond to endoscopic
therapy b) diffuse fundal – often requires
surgery Type III – (isolated FGV) a) secondary to SV thrombosis b) part of generalised PHT Type IV – combination of LCGV+FGV+OV Type V – antral varices
RADIOLOGICAL INVESTIGATION1) USG -to establish diagnosis -to differentiate EHPVO from cirrhosis - extent thrombosis of PV, SV - direction if flow - patency of shunt in post shunt surgery
Portovenogrphy indicated only when surgical or radiological
intervention is required approaches –
spleenoportography arterioportogram
transjugular venography umbilical venography spiral CT angiography
MR angiography
MANAGEMENT OF PORTALHYPERTENSION
PHARMACO THERAPY-1) Splanchnic vasoconstriction
a) Betablockers- propranolol,nadolol,carvedilol
b)Vasopressin's- terlipressin,glypressin, ornipressin c)Hormones somatostatin,octriotide,vapreotide
2)Vasodilators -nitroglycerin - isosorbide-5-mononitrate - isosorbide di nitrates - alpha blockers – prazosin
3) Miscellaneous - metaclopramide - calcium channel blockers - angiotensin blockers-losartan
Indication for pharmacotherapy
1) control of acute variceal bleeding2) bleed from portal hypertensive gastropathy3) Primary prophylaxis & prevention of
recurrent of variceal bleed
ENDOSCOPIC THERAPY
1) ENDOSCOPIC SCLEROTHERAPY sodium morrhuate 5% ethanolamine oleate 5% sodium tetradecyl sulphate 1.5 %
polidocanol 1% cyanocrylate glue
absolute alcohol phenol 3% in water phenol 5% in oil
Mechanism of action- inflammation & secondary thrombosis, phenol causes primary
thrombosis
Site of injection
1) Intravariceal-2-3 ml2) Paravariceal – 1-2 ml3) Combined intra and Intravariceal
Schedule of injection - weekly or 3 weekly - in presence of EST ulcer deferred for a
week - follow-up endoscopy every 3 month for 1 year,
6 monthly in 2 nd year , then yearly
Complication of EST 1) Minor- retrosternal pain -fever - transient dysphagia - superficial ulcers 2) Major-oesophageal perforation - mediastinitis - septicemia - ARDS,pneumonitis - bleeding 3)Major(non fatal)-pleural effusion -stricture 4) Miscellaneous- PV thrombosis, splenic abscess - spinal cord paralysis, brain abscess - broncho oesophageal fistula
EVLAdvantages- effective - faster variceal obliteration - less rebleeding - fewer complicationDisadvantages- higher recurrence - not suitable for small varices - expensive
TIPSEfficacy-85-95%Reccurence-20-30%Hepatic encephalopathy-20-30% (refractory 10%)Stent revision-50%Stent migration, haemmorrhage, haemobilia, sepsis RHFNot effective in fundic varices
Indications for TIPS1) Failure of pharmacological, endoscopic
therapy2) Recurrent bleeding3) Refractory ascites4) Hepatorenal syndrome5) Budd Chiari syndrome
Contraindications to TIPS1) Long standing complete PV obstruction2) Right IJV obstruction3) Pre existing septicaemia4) Hypercoagulable state - It is the procedure of choice in patients poor
liver reserve with severe bleed
Surgical Intervention For Portal Hypertension
A. Emergency surgery for acute bleedingB. Elective surgery as primary therapeutic modalityC. Elective surgery as rescue therapy after failure
of endoscopic therapy
Emergency Surgery For Acute BleedingIndicationsa) Continuing or recurrent bleeding after 2
sessions of EST or EVLb) Significant rebleed -fresh blood in RT,
fall in Hb> 2 gm%, hypotension, BP<80mmHg,blood transfusion > 2 ltr
c) Failure of glue injection for fundic varices Procedure of choice in emergency is modified Suigara procedure – trans abdominal gastro – esophageal devascularisation with gastro esophageal stapling
Elective Surgery as Primary Therapy
I. Absolute indication – left sided portal hypertension, ectopic varices ,symptomatic hypersplenism , symptomatic massive splenomegaly , growth retardation, portal biliopathy
II. Relative indications - diffuse fundal gastric varices ( type IIb & III) , failure of glue injection during injection or recurrence after multiple sessions
Elective Surgery As Rescue Therapy
failure of chronic EST significant rebleed in defaulters
TYPES OF SURGERY
A. Decompressive procedure – portosystemic shunts
B. Non decompressive procedure – devascularisation
C. Liver transplantation
Porta Systemic ShuntsTOTA SHUNTS SELECTIVE SHUNTS PARTIAL SHUNTS
1) Porta caval – end to end, side to side
DSRS( Warren shunt ) Small diameter portacaval(Sarfeh shunt)
2) Central splenorenal – proximal , side to side
Coronocaval
3) Mesocaval – cavo mesenteric , mesocaval H graft
Spleenocaval
Porta caval shunts
A. End to side – choice of shunt surgery when medical management fails
B. Side to side – shunt of choice in Budd-Chiari syndrome ( controls ascites & portal hypertension)
Proximal splenorenal shunt(Linton) rebleed 10-19%Encephalopathy 15-19%Mortality 12-38%Not recommended for cirrhotic patients
MESOCAVAL SHUNTS
I. Interposition H graftII. Cavomesenteric shunt – Indication- ectopic varices Budd-Chiari syndrome when SV is not available or not suitable Advantage- Doesn’t interfere future liver transplant
Side to side Splenorenal Shunt Indications - small diameter splenic vein <7 mm - portal biliopathy & ectopic varices ( both GE junction & mesenteric site
to be decompressed)Prerequisite- SV & Renal should be adequately
mobilisedAdvantages – relieves hypersplenism decreases splenic size
Distal Splenorenal Shunt Distal end of splenic vein is anastamosed to
renal vein Decompresses via short gastric vessels Prerequisite- SV should be at least 1 cm Left gastric vein , right and left
gastroepiploic veins and retrogastric collaterals should be ligated .
Low risk of hepatic encephalopathy 0 – 10 %Five year survival is 85 – 90 %
Disadvantages- more complex shunt thrombosis not suitable when SV is thrombosed
(EHPVO) more distance b/w SV & RV early rebleed ContraindicationsIntractable ascitesMassive splenomegalyIn emergency
Corono-caval shunt(Inokuchi)• Left gastric vein is anastamosed to IVC
Partial Shunts(Sarfeh & Rypnis) small diameter graft b/w PV & IVC graft should be at least 50% of the diameter
of PVRebleed 3.3%Encephalopathy 8-16 %
NON SHUNT SURGERYSuiguira Futugawa procedurea) Devascularisation of lower esophagusb) Oesophageal transectionc) Devascularisation of upper half of lesser
curvatured) Splenectomye) Vagotomyf) Pyloroplasty
Advantages low mortality 5% recurrence rate 0.5% rebleed 1.5%Absence of encephalopathy
ComplicationsOesophageal leak 6%Oesophageal stricture 2%
Hassab’s modification extensive gastro-oesophageal
devascularisation with splenectomy without oesophageal transection
Mathur’s modification• Transabdominal approach• Devascularisation of the upper 2/3 rd of
stomach• Transhiatal devascularisation of lower 10 of
oesophagus• Vagus preservation• Pyloric dilation• Stapled oesophageal transection• Floppy Nissen fundoplication• No splenectomy• Splenic artery ligation for hypeersplenism
Complications1. Anastomotic leak2. Dysphagia3. Gastro-oesophageal reflux4. Recurrent haemorrhage5. Intraperitoneal sepsis
Advantages6. No prior PV anatomical investigation7. Easy8. Spleen is preserved
Contraindication1. Congestive gastropathy2. Ectopic varices3. Postsclerotherapy oesophageal ulcer
bleeding
Liver transplant
Reserved for patients with end stage liver disease
THANK YOU